tiprankstipranks
Advertisement
Advertisement

VTGN Stock Latest News

VistaGen Appoints New Chief Medical Officer to Advance Pipeline
Company AnnouncementsVistaGen Appoints New Chief Medical Officer to Advance Pipeline
8d ago
8K
VTGN
Vistagen appoints Angelov as Chief Medical Officer
PremiumThe Fly
Vistagen appoints Angelov as Chief Medical Officer
8d ago
VTGN
VistaGen Reports Positive Long-Term Data for Fasedienol
PremiumCompany Announcements
VistaGen Reports Positive Long-Term Data for Fasedienol
15d ago
8K
VTGN
Vistagen reports preliminary positive data on ongoing PALISADE-3 study
PremiumThe Fly
Vistagen reports preliminary positive data on ongoing PALISADE-3 study
15d ago
VTGN
VistaGen Completes Phase 3 PALISADE-4 Trial Milestone
PremiumCompany Announcements
VistaGen Completes Phase 3 PALISADE-4 Trial Milestone
19d ago
8K
VTGN
Vistagen announces completion of last patient visit in PALISADE-4 study
PremiumThe FlyVistagen announces completion of last patient visit in PALISADE-4 study
19d ago
VTGN
VistaGen Advances Refisolone Nasal Spray in U.S. Phase 2
Premium
Company Announcements
VistaGen Advances Refisolone Nasal Spray in U.S. Phase 2
29d ago
8K
VTGN
AbCellera target is profile more attractive than Vistagen, says JonesResearch
Premium
The Fly
AbCellera target is profile more attractive than Vistagen, says JonesResearch
1M ago
ABCL
VTGN
Vistagen receives FDA ‘Study May Proceed’ letter under refisolone IND filing
PremiumThe Fly
Vistagen receives FDA ‘Study May Proceed’ letter under refisolone IND filing
1M ago
VTGN
VistaGen Therapeutics Grants Broad Employee Retention Stock Options
PremiumCompany Announcements
VistaGen Therapeutics Grants Broad Employee Retention Stock Options
1M ago
8K
VTGN
VistaGen Faces Nasdaq Audit Committee Compliance Setback
PremiumCompany Announcements
VistaGen Faces Nasdaq Audit Committee Compliance Setback
2M ago
8K
VTGN
VistaGen Showcases Intranasal Pherine Pipeline in New Presentation
PremiumCompany Announcements
VistaGen Showcases Intranasal Pherine Pipeline in New Presentation
2M ago
8K
VTGN
VistaGen Announces Workforce Reduction to Extend Cash Runway
PremiumCompany AnnouncementsVistaGen Announces Workforce Reduction to Extend Cash Runway
3M ago
8K
VTGN
VISTAGEN THERAPEUTICS CLASS ACTION: LEVI & KORSINSKY, LLP EXPLAINS LEAD PLAINTIFF DEADLINE AND PROCESS
Premium
Class Action
VISTAGEN THERAPEUTICS CLASS ACTION: LEVI & KORSINSKY, LLP EXPLAINS LEAD PLAINTIFF DEADLINE AND PROCESS
3M ago
VTGN
Vistagen Facing Class Action over Social Anxiety Disorder Drug Claims
Premium
Market News
Vistagen Facing Class Action over Social Anxiety Disorder Drug Claims
3M ago
VTGN
LEVI & KORSINSKY, LLP: UNDERSTANDING THE LEGAL FRAMEWORK FOR THE VISTAGEN THERAPEUTICS SECURITIES CLASS ACTION
PremiumClass Action
LEVI & KORSINSKY, LLP: UNDERSTANDING THE LEGAL FRAMEWORK FOR THE VISTAGEN THERAPEUTICS SECURITIES CLASS ACTION
3M ago
VTGN
High-Risk Warning: Analyst Flags Significant Uncertainties for Vistagen Therapeutics Investors
PremiumCompany Announcements
High-Risk Warning: Analyst Flags Significant Uncertainties for Vistagen Therapeutics Investors
3M ago
VTGN
Vistagen Therapeutics Balances Progress and Uncertainty
PremiumCompany Announcements
Vistagen Therapeutics Balances Progress and Uncertainty
3M ago
VTGN
Vistagen reports Q3 EPS (45c), consensus (49c)
PremiumThe Fly
Vistagen reports Q3 EPS (45c), consensus (49c)
3M ago
VTGN
VTGN Earnings this Week: How Will it Perform?
PremiumPre-EarningsVTGN Earnings this Week: How Will it Perform?
4M ago
VTGN
VistaGen Receives Nasdaq Notice on Minimum Bid Compliance
Premium
Company Announcements
VistaGen Receives Nasdaq Notice on Minimum Bid Compliance
4M ago
8K
VTGN
Vistagen Therapeutics (VTGN) Faces Securities Litigation Following 80% Stock Collapse [January 2026]
Premium
Class Action
Vistagen Therapeutics (VTGN) Faces Securities Litigation Following 80% Stock Collapse [January 2026]
4M ago
VTGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >